Author

Irene Herranz-Montoya

Observed name: Herranz Montoya, Irene

Institution: Spanish National Cancer Research Centre

Observed institutions: University of Cambridge, Spanish National Cancer Research Centre, MRC Cancer Unit

ORCID: 0000-0001-9644-0585

Observed ORCID: 0000-0001-9644-0585

OpenAlex ID: A5041982382

Fumarate induces vesicular release of mtDNA to drive innate immunity

2023 · Vincent Zecchini, Vincent Paupe, et al. · Nature · 362

A comprehensive analysis of prefoldins and their implication in cancer

2021 · Irene Herranz-Montoya, Solip Park, et al. · iScience · 47

Acyl-coenzyme a binding protein (ACBP) - a risk factor for cancer diagnosis and an inhibitor of immunosurveillance

2024 · Léa Montégut, Peng Liu, et al. · Molecular Cancer · 29

Transit-amplifying cells control R-spondins in the mouse crypt to modulate intestinal stem cell proliferation

2022 · Almudena Chaves-Pérez, Karla Santos-de-Frutos, et al. · The Journal of Experimental Medicine · 19

p53 protein degradation redefines the initiation mechanisms and drives transitional mutations in colorectal cancer

2025 · Irene Herranz-Montoya, Mariana Angulo-Aguado, et al. · Nature Communications · 16

Correction: Acyl-coenzyme a binding protein (ACBP) - a risk factor for cancer diagnosis and an inhibitor of immunosurveillance

2024 · Léa Montégut, Peng Liu, et al. · Molecular Cancer · 2

446 Tumor immunogenic reprogramming sensitizes colorectal cancer to immune checkpoint blockade and reveals a novel therapeutic biomarker

2025 · Mariana Angulo-Aguado, Irene Herranz-Montoya, et al. · Journal for ImmunoTherapy of Cancer

Works count: 9

Citation count: 475

H-index: 5

I10-index: 5